Browse > Article

THE PET/CT IN THE DIAGNOSIS OF ORAL CANCER: CLINICAL CASES  

Kim, Sung-Jin (Department of Oral and Maxillofacial Surgery, Korea Cancer Center Hospital)
Kim, Yong-Kack (Department of Oral and Maxillofacial Surgery, Korea Cancer Center Hospital)
Kim, Chul (Department of Oral and Maxillofacial Surgery, Eulji University Hospital)
Publication Information
Journal of the Korean Association of Oral and Maxillofacial Surgeons / v.31, no.2, 2005 , pp. 178-182 More about this Journal
Abstract
With the development of systemic diagnostic technique in cancer, the diagnostic methods of head and neck region are developing, also. Now, it is usually used computed tomography(CT), magnetic resornance image(MRI) in head and neck cancer and positron emission tomography(PET) is being increased in diagnostic use because of tumor specificity and accuracy. However, CT and MRI show the advantage of showing precise anatomical landmarks, but the disadvantage of these methods is much affecting by anatomical variations and changes. Otherwise, PET presents the imaging of physiologic and biochemical phenomenon and the disadvantage is the difficult differentiation of normal physiologic uptake, the lack of normal anatomical landmarks. PET/CT, the combination of clinical PET and CT imaging in a single unit is introduced recently, and it helps to get more accurate diagnostic interpretation and to improve in evaluating response to therapy, in management of patients with malignant tumors. So, we report the advantages of PET/CT in the diagnosis of oral cancer with review of literatures.
Keywords
CT; MRI; PET; PET/CT;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Uematsu H, Sadato N, Yonekura Y, et al: Coregistration of FDG PET and MRI of the head and neck using normal distribution of FDG. J Nucl Med 1998;39(12):2121-2127
2 Block MI, Patterson GA, Sundaresan RS, et al: Improvement in staging of esophageal cancer with the addition of positron emission tomography. Ann Thorac Surg 1997;64:770-777   DOI   ScienceOn
3 Townsend DW, Beyer T, Kinahan PE, et al: Recent studies with a combined PET/CT scanner. International Congress Series, 24th-26th September 1999, Hokkaido, Japan. Amsterdam: Elsevier Science B.V. p 229-244
4 Hawighorst H, Knapstein PG, Weikel W, et al: Invasive cervix carcinoma( pT2b-pT4a). Value of conventional and pharmacokinetic magnetic resornance image(MRI) in comparison with extensive cross section and histopathologic findings. Radiologe 1997;37:130-138   DOI   ScienceOn
5 Smith TA: FDG uptake, tumor characteristics and response to therapy: a review. Nucl Med Commun 1998;19(2):69-82
6 Shreve PD, Anzai Y, Wahl RL: Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics 1999;19(1):61-77;quiz 150-151   DOI
7 Vansteenkiste JF, Stroobants SG, Dupont PJ, et al: FDG-PET scan in potentially operable non-small lung cancer: do anatometabolic PETCT fusion images improve the localization of regional lymph node metastases? The Leuven Lung Cancer Group. Eur J Nucl Med 1998;25(11):1495-1501   DOI
8 Dwamena BA, Sonnad SS, Angobaldo JO, et al: Metastases from non-small cell lung cancer. Mediastinal staging in the 1990s. Metaanalytic comparison of PET and CT. Radiology 1999;213:530-536   DOI
9 I. Frank Ciernik, Elena Dizendorf, Brigitta G, et al: Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): A feasiblity study. Int J Radiation Oncology Biol Phys 2003;57:853-863   DOI   ScienceOn
10 Maier AG, Kersting-Sommerhoff B, Reeders JW, et al: Staging of rectal cancer by double-contrast MR imaging using the rectally administered superparamagnetic iron oxide contrast agent ferristene and IV gadodiamde injection. Results of a multicenter phase II trial. J Magn Reson Imaging 2000;12:651-660   DOI   ScienceOn
11 Engel H, Steinert H, Buck A, Berthold T, Huch Boni RA, von Schulthess GK: Whole-body PET:physiological and artifactual fluorodeoxyglucose accumulations. J Nucl Med 1996;37(3):441-446
12 Czernin J, Phelps ME: Positron emission tomography scanning. Current and future applications. Ann Rev Med 2002;53:89-112   DOI   ScienceOn
13 Gupta NC, Tamim WJ, Graeber GG, et al: Mediastinal lymph node sampling following positron emission tomography with fluorodeoxyglucose imaging in lung cancer staging. Chest 2001;120:521- 527   DOI   ScienceOn
14 Paul G, Kluetz, Carolyn Cidis Meltzer, et al: Combined PET/CT Imaging in Oncology: Impact on Patient Management. Clinical Positron Imaging 2000;3:223-230   DOI   ScienceOn